We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.49B
AUM Growth
-$310M
Cap. Flow
-$220M
Cap. Flow %
-4%
Top 10 Hldgs %
20.85%
Holding
223
New
43
Increased
76
Reduced
62
Closed
19

Top Buys

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$78M
2
DTM icon
DT Midstream
DTM
+$57.2M
3
WDAY icon
Workday
WDAY
+$50.1M
4
LNG icon
Cheniere Energy
LNG
+$48M
5
BPMC
Blueprint Medicines
BPMC
+$47M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$95.2M
2
WCN
Waste Connections
WCN
+$90.6M
3
TT icon
Trane Technologies
TT
+$86.8M
4
DHI icon
D.R. Horton
DHI
+$68.1M
5
ROL icon
Rollins
ROL
+$57.3M

Sector Composition

Rank Sector Weight
1 Healthcare 37.19%
2 Technology 20.42%
3 Industrials 16.23%
4 Consumer Discretionary 7.92%
5 Energy 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KROS icon
151
Keros Therapeutics
KROS
$202M
$6.02M 0.11%
380,000
– –
INTU icon
152
Intuit
INTU
$86.3B
$5.99M 0.11%
9,519
+3,548
+59% +$2.27M
ANNX icon
153
Annexon
ANNX
$863M
$5.22M 0.1%
+1,017,928
New +$6.26M
CEG icon
154
Constellation Energy
CEG
$94.1B
$4.68M 0.09%
20,862
+12,100
+138% +$3.02M
KRRO icon
155
Korro Bio
KRRO
$151M
$4.48M 0.08%
117,556
-273,610
-70% -$14.1M
YARW
156
Yarrow Bioscience, Inc. Common Stock
YARW
$22M
$4.45M 0.08%
27,887
– –
SLN
157
Silence Therapeutics
SLN
$549M
$4.4M 0.08%
640,000
– –
ENB icon
158
Enbridge
ENB
$121B
$4.14M 0.08%
+98,394
New +$4.12M
LLY icon
159
Eli Lilly
LLY
$1.03T
$3.24M 0.06%
4,198
+70
+2% +$58K
AIP icon
160
Arteris
AIP
$1.35B
$3.24M 0.06%
317,625
– –
AMGN icon
161
Amgen
AMGN
$209B
$2.61M 0.05%
10,049
+5,219
+108% +$1.55M
P
162
Everpure Inc
P
$25B
$2.59M 0.05%
42,189
+2,902
+7% +$162K
UNP icon
163
Union Pacific
UNP
$172B
$2.59M 0.05%
11,366
+1,071
+10% +$254K
PLD icon
164
Prologis
PLD
$136B
$2.44M 0.04%
23,128
-8,553
-27% -$983K
BSX icon
165
Boston Scientific
BSX
$68.4B
$2.43M 0.04%
27,237
+18,482
+211% +$1.63M
RSG icon
166
Republic Services
RSG
$65B
$2.22M 0.04%
11,047
+377
+4% +$78.1K
RF icon
167
Regions Financial
RF
$26.3B
$2.19M 0.04%
+92,441
New +$2.28M
CYBR
168
DELISTED
CyberArk
CYBR
$2.07M 0.04%
6,210
+131
+2% +$39.8K
FFIV icon
169
F5
FFIV
$22.1B
$1.94M 0.04%
7,728
+1
+0% +$239
DT icon
170
Dynatrace
DT
$12.8B
$1.89M 0.03%
34,847
-398
-1% -$21.7K
GWRE icon
171
Guidewire Software
GWRE
$12.8B
$1.86M 0.03%
11,050
+387
+4% +$72.3K
TW icon
172
Tradeweb Markets
TW
$20.8B
$1.82M 0.03%
+13,886
New +$1.83M
PBA icon
173
Pembina Pipeline
PBA
$29.3B
$1.68M 0.03%
+45,714
New +$1.86M
PCTY icon
174
Paylocity
PCTY
$7.32B
$1.63M 0.03%
8,176
+1,183
+17% +$226K
JKHY icon
175
Jack Henry & Associates
JKHY
$11B
$1.6M 0.03%
9,136
-5
-0.1% -$894
5 6
7
8 9

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Eventide Asset Management held 223 positions worth $5.49B, down 5.3% from $5.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Eventide Asset Management withdrew a net $220M in Q4 2024, closing 19 positions and reducing 62 holdings. Its most notable exit was Idexx Laboratories, an estimated $95.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in GE Vernova worth $82.1M.

  • Eventide Asset Management's largest Q4 2024 buy was GE Vernova: 249,514 shares worth $82.1M.
  • Eventide Asset Management added most to Workday in Q4 2024, an estimated $50.1M increase.
  • Eventide Asset Management's biggest Q4 2024 reduction was Waste Connections, cutting an estimated $90.6M.
  • Eventide Asset Management fully exited Idexx Laboratories in Q4 2024, selling an estimated $95.2M.
  • Eventide Asset Management's ten largest holdings make up 21% of its $5.49B portfolio in Q4 2024.
  • Eventide Asset Management opened 43 new positions and closed 19 in Q4 2024.
  • Eventide Asset Management's portfolio value fell 5.3% quarter-over-quarter to $5.49B.

Based on Eventide Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.